Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.52%
+3.51%
+210.53%
+1.67%
Most Trending
-2.52%
+3.51%
+210.53%
+1.67%
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
07 Oct 2025$TMQ stole the spotlight with a jaw-dropping 210% surge to $6.55 after the White House announced it would take a 10% equity stake in the Canadian minerals explorer. This marks a dramatic shift in United States industrial policy, with the government now holding positions in five publicly traded companies focused on critical minerals and semiconductors. Trading volume exploded to 198.40 million shares versus its typical 1.97 million, while technical indicators flashed overbought warnings with the RSI at extreme levels and MACD crossing bullishly. The massive volume spike suggests institutional backing, though traders should note that South32 sold its stake just as the government bought in.
$BURU rocketed 84% to $0.47 on the news that NUBURU will acquire Orbit, expanding its defense and security footprint. The company is targeting a $3.6 billion market opportunity in defense-grade SaaS platforms. Volume surged to 775.92 million shares, roughly eight times normal activity, indicating strong conviction though the low absolute price means continued volatility is likely.
$LXEO climbed 29% to $8.36 after Lexeo Therapeutics announced progress in FDA discussions for an accelerated approval pathway for LX2006, its Friedreich ataxia cardiomyopathy treatment, along with positive interim clinical data. Volume jumped to 8.89 million shares from an average 625,000, showing the biotech community enthusiasm for the potentially shortened path to commercialization.
$AEHR crashed 17.57% to $26.15 despite meeting earnings expectations at $0.01 per share. Management's refusal to reinstate guidance due to tariff concerns triggered selling pressure, with volume quadrupling to 7.76 million shares. The lack of forward visibility signals deeper worries about demand and pricing power in the semiconductor equipment market.
$HUMA suffered the day worst decline, plummeting 33.67% to $1.65 after pricing a $60 million direct offering. The dilution fears sent volume soaring to 34.04 million shares from typical 3.56 million as shareholders rushed for exits, despite D. Boral Capital maintaining a buy rating with a 281% upside target.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
